Uviquity secures $6.6 million in seed funding to advance far-UVC disinfection technology, led by Emerald Development Managers.
Uviquity secures $6.6 million in seed funding to advance far-UVC disinfection technology, led by Emerald Development Managers.
05/07/25, 2:04 PM
Location
Money raised
$6.6 million
Industry
manufacturing
Round Type
seed
Investors
Mann+Hummel, Ag Funder, Emerald Development Managers
Uviquity, a North Carolina-based startup, has emerged from stealth with $6.6 million in seed funding to develop its far-UVC light technology for pathogen control. The funding round was led by Emerald Development Managers, with contributions from AgFunder and MANN+HUMMEL. The company aims to make far-UVC disinfection practical and safe for use around people. CEO Scott Burroughs emphasizes the importance of this technology in enhancing public safety against pathogens.
Company Info
Location
1017 main campus drive, suite 2342
raleigh, north carolina, united states
Additional Info
Uviquity is a deep tech, venture-backed startup working at the leading edge of wide bandgap semiconductors and integrated photonics.
We use proprietary photonics to create a new kind of semiconductor chip that generates human safe, pathogen-eliminating far-UVC light. Air, food and water can be made germ free, at scale.